Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
EBMT
|
Kenneth M Walsh
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 7.35% |
$151,100
$15.11 p/Share
|
Feb 05
2025 |
AXP
|
Raymond Joabar
Grp. Pres., GMNS |
SELL
Open market or private sale
|
Direct | 11,121 Reduced 46.6% |
$3,525,468
$317.01 p/Share
|
Feb 05
2025 |
SPT
|
Joseph Del Preto
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 0.99% |
$50,460
$33.64 p/Share
|
Feb 05
2025 |
HBT
|
Patrick F Busch
Director |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 0.0% |
$198,160
$24.77 p/Share
|
Feb 05
2025 |
CBSH
|
David L. Roller
Senior Vice President |
SELL
Open market or private sale
|
Direct | 3,348 Reduced 9.73% |
$227,027
$67.81 p/Share
|
Feb 05
2025 |
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$25,240
$12.62 p/Share
|
Feb 05
2025 |
AGNC
|
Frances Spark
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 6.18% |
$50,500
$10.1 p/Share
|
Feb 05
2025 |
CBSH
|
David L Orf
Exec. Vice President & CCO |
SELL
Open market or private sale
|
Direct | 1,036 Reduced 4.46% |
$70,696
$68.24 p/Share
|
Feb 05
2025 |
HNVR
|
Robert Golden
Director |
SELL
Open market or private sale
|
Indirect | 2,761 Reduced 0.0% |
$73,470
$26.61 p/Share
|
Feb 05
2025 |
NWFL
|
Ronald R Schmalzle |
BUY
Open market or private purchase
|
Indirect | 8,500 Added 0.0% |
$226,015
$26.59 p/Share
|
Feb 05
2025 |
PRTFTM
|
Rad Investments LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 42,490 Added 1.08% |
$29,318
$0.69 p/Share
|
Feb 05
2025 |
FRST
|
Susan B Williamson
EVP, Director of Reg Relations |
BUY
Open market or private purchase
|
Direct | 220 Added 3.78% |
$2,431
$11.05 p/Share
|
Feb 05
2025 |
CLS
|
Robert Mionis
President & CEO |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 14.11% |
$10,638,000
$141.84 p/Share
|
Feb 05
2025 |
NOC
|
Mark A Welsh Iii
Director |
SELL
Open market or private sale
|
Direct | 33 Reduced 0.8% |
$15,837
$479.93 p/Share
|
Feb 05
2025 |
SLAB
|
Navdeep S Sooch
Director |
SELL
Open market or private sale
|
Direct | 2,360 Reduced 0.59% |
$351,640
$149.0 p/Share
|
Feb 05
2025 |
CVCO
|
Matthew A Nino
President, Retail |
SELL
Open market or private sale
|
Direct | 894 Reduced 53.69% |
$472,952
$529.03 p/Share
|
Feb 05
2025 |
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 41,193 Reduced 0.0% |
$502,554
$12.2 p/Share
|
Feb 05
2025 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 914 Added 0.0% |
$2,550
$2.79 p/Share
|
Feb 05
2025 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 328 Added 0.58% |
$915
$2.79 p/Share
|
Feb 05
2025 |
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 42,294 Reduced 0.0% |
$659,363
$15.59 p/Share
|
Feb 05
2025 |
BANF
|
F Ford Drummond
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 100.0% |
$602,900
$120.58 p/Share
|
Feb 05
2025 |
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 24,139 Reduced 0.0% |
$286,288
$11.86 p/Share
|
Feb 05
2025 |
FNB
|
William B Campbell
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 1.85% |
$46,710
$15.57 p/Share
|
Feb 05
2025 |
BFZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 58,256 Reduced 0.0% |
$660,623
$11.34 p/Share
|
Feb 05
2025 |
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$1,393
$1393.56 p/Share
|
Feb 05
2025 |
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.46% |
$40,005
$80.01 p/Share
|
Feb 05
2025 |
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.0% |
$47,952
$79.92 p/Share
|
Feb 05
2025 |
RRBI
|
Teddy Ray Price
Director |
BUY
Open market or private purchase
|
Indirect | 110 Added 0.0% |
$6,340
$57.64 p/Share
|
Feb 05
2025 |
RRBI
|
Teddy Ray Price
Director |
BUY
Open market or private purchase
|
Direct | 549 Added 0.15% |
$31,583
$57.53 p/Share
|
Feb 05
2025 |
PWOD
|
Charles E. Kranich
Director |
BUY
Open market or private purchase
|
Direct | 200 Added 0.53% |
$6,236
$31.18 p/Share
|
Feb 05
2025 |
Ctth
|
Ctt Pharmaceutical Holdings, Inc.
CEO |
BUY
Open market or private purchase
|
Direct | 5,200 Added 0.08% |
$624
$0.12 p/Share
|
Feb 05
2025 |
USEG
|
Ryan Lewis Smith
CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.06% |
$1,155
$2.31 p/Share
|
Feb 05
2025 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 42,614 Reduced 0.0% |
$30,204,377
$708.79 p/Share
|
Feb 05
2025 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 362 Reduced 0.0% |
$253,660
$700.72 p/Share
|
Feb 05
2025 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 12,613 Reduced 0.0% |
$8,941,355
$708.9 p/Share
|
Feb 05
2025 |
SPRO
|
Timothy Keutzer
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 56,537 Reduced 7.09% |
$44,098
$0.78 p/Share
|
Feb 05
2025 |
SPRO
|
Esther Rajavelu
CFO & CBO |
SELL
Open market or private sale
|
Direct | 20,689 Reduced 2.78% |
$16,137
$0.78 p/Share
|
Feb 05
2025 |
SPRO
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct | 69,219 Reduced 9.12% |
$53,990
$0.78 p/Share
|
Feb 05
2025 |
SPRO
|
Sath Shukla
CEO & President |
SELL
Open market or private sale
|
Direct | 155,333 Reduced 8.21% |
$121,159
$0.78 p/Share
|
Feb 05
2025 |
EVCM
|
Matthew David Feierstein
President |
SELL
Open market or private sale
|
Direct | 5,513 Reduced 0.25% |
$55,515
$10.07 p/Share
|
Feb 05
2025 |
OTIS
|
Judith Fran Marks
Chair, CEO and President |
SELL
Open market or private sale
|
Direct | 38,012 Reduced 13.39% |
$3,588,712
$94.41 p/Share
|
Feb 05
2025 |
OTIS
|
Nora E. La Freniere
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 4,775 Reduced 16.08% |
$450,807
$94.41 p/Share
|
Feb 05
2025 |
FENC
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.59% |
$66,600
$6.66 p/Share
|
Feb 05
2025 |
SYM
|
Carol J. Hibbard
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,055 Reduced 8.37% |
$124,488
$30.7 p/Share
|
Feb 05
2025 |
ENSG
|
Christopher R. Christensen
Executive Chairman |
SELL
Open market or private sale
|
Direct | 39,086 Reduced 75.71% |
$5,815,215
$148.78 p/Share
|
Feb 05
2025 |
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,250 Reduced 0.58% |
$120,275
$5.66 p/Share
|
Feb 05
2025 |
FOXA
|
Adam G. Ciongoli
Chief Legal and Policy Officer |
SELL
Open market or private sale
|
Indirect | 84 Reduced 0.0% |
$4,546
$54.13 p/Share
|
Feb 05
2025 |
FOXA
|
Adam G. Ciongoli
Chief Legal and Policy Officer |
SELL
Open market or private sale
|
Indirect | 1,194 Reduced 0.0% |
$64,631
$54.13 p/Share
|
Feb 05
2025 |
RBRK
|
Arvind Nithrakashyap
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 32,485 Reduced 12.9% |
$2,435,725
$74.98 p/Share
|
Feb 05
2025 |
ZIP
|
Ian H. Siegel
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 9,722 Reduced 0.0% |
$76,998
$7.92 p/Share
|
Feb 05
2025 |